Effect of Paritaprevir/Ritonavir/Ombitasvir/Dasabuvir and Ledipasvir/Sofosbuvir Regimens on Survival Compared With Untreated Hepatitis C Virus-Infected Persons: Results From ERCHIVES.

Butt, Adeel Ajwad

Effect of Paritaprevir/Ritonavir/Ombitasvir/Dasabuvir and Ledipasvir/Sofosbuvir Regimens on Survival Compared With Untreated Hepatitis C Virus-Infected Persons: Results From ERCHIVES. [electronic resource] - Clinical infectious diseases : an official publication of the Infectious Diseases Society of America Sep 2017 - 1006-1011 p. digital

Publication Type: Journal Article

1537-6591

10.1093/cid/cix364 doi


2-Naphthylamine
Aged
Anilides--therapeutic use
Antiviral Agents--therapeutic use
Benzimidazoles--therapeutic use
Carbamates--therapeutic use
Cyclopropanes
Drug Therapy, Combination
Female
Fluorenes--therapeutic use
Hepatitis C, Chronic--drug therapy
Humans
Kaplan-Meier Estimate
Lactams, Macrocyclic
Macrocyclic Compounds--therapeutic use
Male
Middle Aged
Proline--analogs & derivatives
Propensity Score
Proportional Hazards Models
Ritonavir--therapeutic use
Sofosbuvir--therapeutic use
Sulfonamides--therapeutic use
Survival Rate
Sustained Virologic Response
Uracil--analogs & derivatives
Valine